BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27729735)

  • 1. Recent advances in mass spectrometry-based proteomics of gastric cancer.
    Kang C; Lee Y; Lee JE
    World J Gastroenterol; 2016 Oct; 22(37):8283-8293. PubMed ID: 27729735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of mass spectrometry in proteomics.
    Guerrera IC; Kleiner O
    Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry for protein identification and the study of post translational modifications.
    Salzano AM; Crescenzi M
    Ann Ist Super Sanita; 2005; 41(4):443-50. PubMed ID: 16569912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
    Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
    J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What gastric cancer proteomic studies show about gastric carcinogenesis?
    Leal MF; Wisnieski F; de Oliveira Gigek C; do Santos LC; Calcagno DQ; Burbano RR; Smith MC
    Tumour Biol; 2016 Aug; 37(8):9991-10010. PubMed ID: 27126070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difference analysis on proteome of Helicobacter pylori in patients with peptic ulcer, gastritis, and gastric cancer].
    Zhang J; Ding SG; Zhong LJ; Lin SR; Yang B; Peng JR; Lou YX
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2690-4. PubMed ID: 17199978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in quantitative proteomics using stable isotope tags.
    Flory MR; Griffin TJ; Martin D; Aebersold R
    Trends Biotechnol; 2002 Dec; 20(12 Suppl):S23-9. PubMed ID: 12570156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
    Mohri Y; Toiyama Y; Kusunoki M
    Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
    Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of food proteins and peptides by mass spectrometry-based techniques.
    Mamone G; Picariello G; Caira S; Addeo F; Ferranti P
    J Chromatogr A; 2009 Oct; 1216(43):7130-42. PubMed ID: 19699482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in top-down proteomics for disease biomarker discovery.
    Calligaris D; Villard C; Lafitte D
    J Proteomics; 2011 Jun; 74(7):920-34. PubMed ID: 21477672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
    Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
    Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
    Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
    J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow field-flow fractionation: a pre-analytical method for proteomics.
    Reschiglian P; Moon MH
    J Proteomics; 2008 Aug; 71(3):265-76. PubMed ID: 18602503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving in-depth proteomics profiling by mass spectrometry.
    Ahn NG; Shabb JB; Old WM; Resing KA
    ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
    Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
    Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
    Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
    Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based proteomics in the life sciences.
    Lane CS
    Cell Mol Life Sci; 2005 Apr; 62(7-8):848-69. PubMed ID: 15868409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.